ライフサイエンスコーパス: radiation oncology

1 ges of imaging-based treatment adaptation in radiation oncology.

2 ions of nanotechnology within the context of radiation oncology.

3 g the use of imaging for therapy planning in radiation oncology.

4 he various applications of nanotechnology in radiation oncology.

5 uropsychology, ophthalmology, pathology, and radiation oncology.

6 the banked clinical successes in gynecologic radiation oncology.

7 design genomically-guided clinical trials in radiation oncology.

8 y and Oncology who had completed training in radiation oncology.

9 tem changes on the practice of radiology and radiation oncology.

10 design genomically-guided clinical trials in radiation oncology.

11 Fifteen percent of positions were in radiation oncology, 52% in general diagnostic radiology,

12 niversity School of Medicine's Department of Radiation Oncology and Cancer Institute.

13 a brief update of the latest developments in radiation oncology and describes the current best practi

14 sent a framework for the value discussion in radiation oncology and identify approaches for attaining

15 riod (several days), which is beneficial for radiation oncology and imaging.

16 ng both the American Society for Therapeutic Radiation Oncology and Phoenix criteria.

17 targeting of lesions, with implications for radiation oncology and surgical planning.

18 f Radiology (ACR) In-Training Examination in Radiation Oncology and the American Board of Radiology (

19 mbers of the European Society of Therapeutic Radiation Oncology and the American Society for Therapeu

20 e role of surgery in relation to medical and radiation oncology, and argue that surgery must be inclu

21 cology, surgical oncology, medical oncology, radiation oncology, and nursing was formed and tasked wi

22 ting medical hematology/oncology, radiology, radiation oncology, and pathology to review currently us

23 y of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology pan

24 y of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology.

25 mains the main molecular imaging modality in radiation oncology applications.

26 the ASTRO guideline, published in Practical Radiation Oncology, are clear, thorough, and based on th

27 Radiation oncology as a specialty has recently become a

28 The American Society for Radiation Oncology (ASTRO) guideline content and recomme

29 Surgical Oncology (SSO)/American Society for Radiation Oncology (ASTRO) guideline on surgical margins

30 Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-based gu

31 Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-based gu

32 Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-based gu

33 The American Society for Radiation Oncology (ASTRO) produced an evidence-based gu

34 he American Board of Radiology (ABR) Written Radiation Oncology Board Examination.

35 of hypofractionation is gaining momentum in radiation oncology centres, enabled by recent advances i

36 trials are highlighted, with an emphasis on radiation oncology clinical trials.

37 Despite tremendous gains, the radiation oncology community continues to struggle with

38 18F-FDG PET offers the radiation oncology community the ability to incorporate

39 rding to the American Society of Therapeutic Radiation Oncology Consensus Statement, and toxicity was

40 res, through the cooperation of six academic radiation oncology departments, for residents-in-trainin

41 a trends database for all U.S. radiology and radiation oncology departments.

42 prostate carcinoma who were referred to the radiation oncology division between January 1, 1994, and

43 This review will primarily focus on radiation oncology examples, will address issues regardi

44 are units, positron emission tomography, and radiation oncology facilities is associated with greater

45 pread rapidly in both academic and community radiation oncology facilities.

46 Radiation oncology fellowship graduates often had poorer

47 ls have been used in many different areas of radiation oncology for imaging and treatment planning, a

48 artments of radiology and six departments of radiation oncology from areas with low, medium, or high

49 esearch Programs Committee and Department of Radiation Oncology, Gail and Joseph Gassner Development

50 rvey of surviving participants in the Proton Radiation Oncology Group (PROG) 9509--a randomized trial

51 he authors surveyed diagnostic radiology and radiation oncology groups regarding finances, workload,

52 A recent American Society for Radiation Oncology guideline and systematic review, prev

53 cology convened a panel of medical oncology, radiation oncology, guideline implementation, and advoca

54 (ASCO) convened a panel of medical oncology, radiation oncology, guideline implementation, and advoca

55 the space radiation environment and used in radiation oncology, has potentially greater carcinogenic

56 Advances in radiation oncology have been made on three major fronts:

57 and intensity modulated radiation therapy in radiation oncology have resulted in substantial changes

58 In radiation oncology, hyperthermia is known to radiosensit

59 priority areas, including surgical oncology, radiation oncology, imaging, health systems and health d

60 one of the most important success stories in radiation oncology in the latter half of the twentieth c

61 The advancements in radiation oncology in the past 50 years in the United St

62 Radiation oncology is a cornerstone in the treatment of

63 Radiation oncology is essential in the management of bre

64 Theragnostic imaging for radiation oncology is the use of molecular and functiona

65 iewed by a multidisciplinary group (surgery, radiation oncology, medical oncology, and pathology) and

66 iplines that includes head and neck surgery, radiation oncology, medical oncology, medical imaging, c

67 ies are also well suited for applications in radiation oncology, nanomaterials have been used in many

68 medical oncology, neuro-oncology, neurology, radiation oncology, neurosurgery, and ophthalmology met

69 Furthermore, strong collaboration between radiation oncology, nuclear medicine/radiology, and medi

70 ciplines of otolaryngology, palliative care, radiation oncology, oncology, nutrition, speech, and phy

71 charged home after a week and referred for a radiation oncology opinion.

72 ng plays a central role in the management of radiation oncology patients.

73 sis should be placed on adequate training of radiation oncology personnel to understand the potential

74 The MROQC includes academic and community radiation oncology practices across Michigan.

75 questionnaire was mailed to all graduates of radiation oncology programs and to a stratified, random

76 increasing presence of molecular imaging in radiation oncology, special emphasis should be placed on

77 Further advances in the palliative radiation oncology subspecialty will require integration

78 onvened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology,

79 onvened an Expert Panel of medical oncology, radiation oncology, surgical oncology, gastroenterology,

80 e of experts in medical oncology, pathology, radiation oncology, surgical oncology, guideline impleme

81 ASCO convened a panel of medical oncology, radiation oncology, surgical oncology, palliative care,

82 on is arguably the greatest challenge facing radiation oncology, the greatest impact that molecular i

83 Radiation oncology utilization rate added 11 procedures

84 Klopp et al, published in 2014 in Practical Radiation Oncology, was reviewed for developmental rigor

85 a result of the aging US population, but the radiation oncology workforce has not been studied.

86 Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of